Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
The body cannot repair or replace large sections of damaged bone. This 3D printing technology holds promise for supplementing patient's skeletal healing abilities.
DNA from three parents, two female and one male, unite to help a couple overcome the gene expression that caused their first two children to die from Leigh…
Researchers at the University of British Columbia have created a synthetic heart valve that has the potential to reduce costs and improve efficiencies of surgical training programs. The…
Using a neurological interface to control a mechanical exoskeleton might help paralyzed individuals regain partial control of their biological skeleton.
